Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Accuray
ARAY
$33.2M
| $1.4M | ﹤0.01% |
324,836
+254,938
| +365% | +$1.17M |
|
3977
Seres Therapeutics
MCRB
$45.6M
| $1.4M | ﹤0.01% |
+6,883
| New | +$1.41M |
|
|
CVSA
3978
Covista Inc
CVSA
$4.49B
| $1.4M | ﹤0.01% |
33,160
-63,543
| -66% | -$2.49M |
|
3979
Sonida Senior Living
SNDA
$1.88B
| $1.4M | ﹤0.01% |
6,891
-4,730
| -41% | -$1.01M |
|
3980
Vishay Intertechnology
VSH
$5.38B
| $1.4M | ﹤0.01% |
67,240
-199,308
| -75% | -$4.26M |
|
|
KERX
3981
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.4M | ﹤0.01% |
300,100
+157,900
| +111% | +$870K |
|
3982
CALL
Fair Isaac
FICO
$23.5B
| $1.39M | ﹤0.01% |
9,100
-1,100
| -11% | -$166K |
|
3983
Rollins
ROL
$17.4B
| $1.39M | ﹤0.01% |
+67,412
| New | +$1.38M |
|
3984
CALL
Jacobs Solutions
J
$16.9B
| $1.39M | ﹤0.01% |
25,509
-726
| -3% | -$37.2K |
|
|
QEP
3985
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $1.39M | ﹤0.01% |
145,400
+300
| +0.2% | +$2.72K |
|
|
INVX
3986
Innovex International
INVX
$2.18B
| $1.39M | ﹤0.01% |
29,141
-5,694
| -16% | -$254K |
|
3987
CALL
Kirby Corp
KEX
$7.32B
| $1.39M | ﹤0.01% |
20,800
+12,900
| +163% | +$846K |
|
3988
Ferrari
RACE
$72.9B
| $1.39M | ﹤0.01% |
13,253
-19,372
| -59% | -$2.15M |
|
3989
Vanguard Materials ETF
VAW
$3.07B
| $1.39M | ﹤0.01% |
+10,158
| New | +$1.35M |
|
3990
CALL
AeroVironment
AVAV
$9.76B
| $1.39M | ﹤0.01% |
24,700
+2,600
| +12% | +$132K |
|
3991
CALL
TAL Education Group
TAL
$6.46B
| $1.39M | ﹤0.01% |
46,700
-98,800
| -68% | -$3M |
|
3992
Orthofix Medical
OFIX
$421M
| $1.39M | ﹤0.01% |
25,344
+14,031
| +124% | +$728K |
|
3993
ResMed
RMD
$32.4B
| $1.38M | ﹤0.01% |
16,334
-534,621
| -97% | -$44.2M |
|
|
TGH
3994
DELISTED
Textainer Group Holdings limited
TGH
| $1.38M | ﹤0.01% |
64,353
+32,266
| +101% | +$666K |
|
3995
CALL
Guidewire Software
GWRE
$14.6B
| $1.38M | ﹤0.01% |
18,600
+13,000
| +232% | +$1M |
|
3996
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
| $1.38M | ﹤0.01% |
+41,421
| New | +$1.32M |
|
3997
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$481M
| $1.38M | ﹤0.01% |
+21,641
| New | +$1.36M |
|
3998
CALL
Green Plains
GPRE
$1.09B
| $1.38M | ﹤0.01% |
81,800
-39,800
| -33% | -$700K |
|
3999
Invesco Semiconductors ETF
PSI
$2.61B
| $1.38M | ﹤0.01% |
+81,891
| New | +$1.42M |
|
4000
Invesco Dorsey Wright Energy Momentum ETF
PXI
$55.5M
| $1.38M | ﹤0.01% |
+34,856
| New | +$1.27M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.